High Tech Pharm Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
High Tech Pharm has a total shareholder equity of ₩113.9B and total debt of ₩16.9B, which brings its debt-to-equity ratio to 14.9%. Its total assets and total liabilities are ₩142.3B and ₩28.4B respectively. High Tech Pharm's EBIT is ₩16.5B making its interest coverage ratio 19.1. It has cash and short-term investments of ₩7.5B.
Belangrijke informatie
14.9%
Verhouding schuld/eigen vermogen
₩16.95b
Schuld
| Rente dekkingsratio | 19.1x |
| Contant | ₩7.54b |
| Aandelen | ₩113.95b |
| Totaal verplichtingen | ₩28.37b |
| Totaal activa | ₩142.32b |
Recente financiële gezondheidsupdates
Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?
Aug 06
Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt
Feb 23Recent updates
A Look At The Intrinsic Value Of High Tech Pharm Co., Ltd. (KOSDAQ:106190)
Oct 23Is High Tech Pharm (KOSDAQ:106190) Using Too Much Debt?
Aug 06Subdued Growth No Barrier To High Tech Pharm Co., Ltd. (KOSDAQ:106190) With Shares Advancing 25%
Jul 02There's Reason For Concern Over High Tech Pharm Co., Ltd.'s (KOSDAQ:106190) Massive 25% Price Jump
May 09Is High Tech Pharm (KOSDAQ:106190) A Risky Investment?
Apr 23We Think High Tech Pharm (KOSDAQ:106190) Has A Fair Chunk Of Debt
Feb 23Did High Tech Pharm's (KOSDAQ:106190) Share Price Deserve to Gain 91%?
Jan 19What Is The Ownership Structure Like For High Tech Pharm Co., Ltd. (KOSDAQ:106190)?
Dec 15Analyse van de financiële positie
Kortlopende schulden: A106190's short term assets (₩65.1B) exceed its short term liabilities (₩22.7B).
Langlopende schulden: A106190's short term assets (₩65.1B) exceed its long term liabilities (₩5.7B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: A106190's net debt to equity ratio (8.3%) is considered satisfactory.
Schuld verminderen: A106190's debt to equity ratio has increased from 10.4% to 14.9% over the past 5 years.
Schuldendekking: A106190's debt is well covered by operating cash flow (40.1%).
Rentedekking: A106190's interest payments on its debt are well covered by EBIT (19.1x coverage).